Results 151 to 160 of about 45,385 (273)

Target‐Specific Dermatological Adverse Event Reporting With T‐Cell–Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016–2026

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background T‐cell–engaging bispecific antibodies are increasingly utilised in haematological malignancies and are beginning to be adopted in solid‐tumour treatment protocols. Cytokine release syndrome and neurotoxicity are well recognised, but target‐specific dermatological adverse event reporting patterns remain poorly defined.
Saikat Mandal, Manideepa Maji, Arkadeep Dhali   +2 more
wiley   +1 more source

Effect of aesthetic crown lengthening on life quality and self‐esteem: 2‐year study

Clinical Advances in Periodontics, Volume 16, Issue 3, Page 703-711, September 2026.
Abstract Background A gummy smile can result from several factors, often leading to a disharmonious appearance and causing physical and psychological discomfort for the patient. This study aimed to evaluate changes in self‐esteem and quality of life for patients, as well as the recidivism rate, following aesthetic crown lengthening (ACL) surgery ...
Leticia S. Arroteia, Camila S. Stolf, Hélvis E. S. Paz, Thais F. M. Paschoal, Mabelle F. Monteiro, Márcio Z. Casati, Mauro P. Santamaria, Renato C. V. Casarin   +7 more
wiley   +1 more source

Investigation of the Prevalence of the <i>HLA-B*15:02</i> Allele in the Asian Populations: A Comprehensive Analysis Through Using AFND. [PDF]

Health Sci Rep
Biswas M, Murad MA, Ershadian M, Sukasem C.   +3 more
europepmc   +1 more source

Valproate-Associated Hyperammonemic Encephalopathy Despite Nontoxic Serum Levels and Preserved Liver Function: A Case Report. [PDF]

Cureus
Ferreira I, Pais F, Gonçalves E.
europepmc   +1 more source

Favorable Neurological Outcome Following Prolonged Super‐Refractory Status Epilepticus in a Resource‐Limited Setting: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Super‐refractory status epilepticus (SRSE) is associated with high mortality and poor neurological outcomes. This case highlights a young male treated for SRSE. Diagnosis and treatment were expansive. Despite the severity of the patient's disease course, the patient had a favorable neurological outcome at the end of his hospital stay.
Amanda Sang, Allana Yearwood, Keevan Singh, Vaughn Lalla, Kamille Abdool   +4 more
wiley   +1 more source

Phenytoin-induced drug rash with eosinophilia and systemic symptoms syndrome in a child: A rare but serious adverse drug reaction. [PDF]

Indian J Pharmacol
Rajani HS, Narayanappa D, Prashanth SN, Chandrashekhar C.   +3 more
europepmc   +1 more source

Ganoderic Acid A Ameliorates Pentylenetetrazol‐Induced Epilepsy in Mice via Activating KCNQ2

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
GA‐A binds and activates KCNQ2, thereby reducing epileptic‐like EEG discharges, the loss and apoptosis of hippocampal neurons, and improving anxiety and depression‐like behavioral changes. In addition, GA‐A inhibits neuroinflammation and alleviates oxidative stress independent of activating KCNQ2.
Yang Yao, Zhujun Liu, Xujiao Wang, Cunhao Bian, Rui Wang, Yukun Zhang   +5 more
wiley   +1 more source

Ertapenem-Associated Neurotoxicity in a Patient With Chronic Kidney Disease and Hypothyroidism: A Case Report. [PDF]

Cureus
Elfatih Mohamed M, Ockba EAI, Khan A.
europepmc   +1 more source

Association of decreased CYP2C9 function, <i>HLA-B*40:06</i>, and hemoglobin levels with phenytoin-induced cutaneous adverse reactions in a Southern Thai population. [PDF]

Front Pharmacol
Seree-Aphinan C, Sangiemchoey A, Setthawatcharawanich S, Pattharachayakul S, Hnoonual A, Ruanglertboon W, Intapiboon P, Kaewborisutsakul A, Thamcharoenvipas T, Rachatawiriyakul P, Chongsuvivatwong T, Sittipong S, Sukasem C, Jaruthamsophon K.   +13 more
europepmc   +1 more source

Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat.

, 1991
The effect of coadministration of bupropion (50 mg kg-1, p.o.) on the disposition profile of phenytoin has been studied in the rat. Plasma phenytoin concentration was measured serially for 10 h by HPLC.
al-Khamis KI, Tekle A
core